Jump to Main Contents
ncc en

Annual Report 2020

Department of Plastic and Reconstructive Surgery

Takuya Higashino, Azusa Oshima, Yutaka Fukunaga, Ayako Takaya, Jun Oba, Ayumi Suzuki

Introduction

 The Department of Plastic and Reconstructive Surgery has focused on surgical reconstruction following cancer ablation. In our institution, reconstructive procedures using free flap transfer with microvascular anastomosis are the most important operations. In addition, several methods such as tissue transfer with pedicled flaps, local flaps, and skin grafting are used for reconstructive surgery. The objectives of reconstructive surgery are not only the morphological reconstruction, but also the restoration of postoperative functions after ablative surgery. The quality of life (QOL) of patients can be improved with functional and morphological reconstruction.

The Team and What We Do

 Three plastic surgeons cover reconstructive operations in the National Cancer Center Hospital (NCCH) East in Kashiwa. The reconstructive surgeries are performed in cooperation with surgeons of other departments within the hospital, such as the Departments of Head and Neck Surgery, Breast Surgery, Esophageal Surgery, Thoracic Surgery, Colorectal Surgery, and Urology (Table 1). In the NCCH East, head and neck reconstruction is the most frequently performed operation accounting for approximately 50% of the reconstructive surgeries. Free jejunal transfer, anterolateral thigh flap transfer, and rectus abdominis musculocutaneous flap transfer are the frequently used procedures in the head and neck region (Table 2). A weekly conference is held with doctors of the Departments of Head and Neck Surgery, Radiation Oncology, and Head and Neck Medical Oncology. Breast reconstruction using autologous tissue transfer was employed in 2003. Since then, patients’ needs for breast reconstruction have increased. Furthermore, lymphatico-venular anastomosis as a surgical treatment for lymphedema of the extremities was introduced in 2013.

Table 1. Number of patients (April, 2020 – March, 2021)
Table 1. Number of patients (April, 2020 – March, 2021)

Table 1. Number of patients (April, 2020 – March, 2021)
Table 1. Number of patients (April, 2020 – March, 2021)

Table 2. Operative procedures (April, 2020 – March, 2021)
Table 2. Operative procedures (April, 2020 – March, 2021)

Table 2. Operative procedures (April, 2020 – March, 2021)
Table 2. Operative procedures (April, 2020 – March, 2021)

Research activities

 Plastic and reconstructive surgery has focused on the following four aspects in the surgical treatment of cancer for the purpose of contributing to improving patients’ QOL: 1) obtaining good functional recovery, 2) reducing postoperative complications, 3) achieving less donor site morbidity, and 4) treating postoperative complications after cancer ablation. With the objective of addressing these four aspects establishing a standard for reconstructive surgery and developing new techniques of reconstructive surgery are the most important aims of our studies. In 2017, we started to take an active role in a new multi-institutional analysis of risk factors for functional outcomes after tongue reconstruction.

Education

 We accept a large number of young plastic surgeons from all over Japan as residents and train them to become reconstructive surgeons. We also train them to become future opinion leaders in the field of reconstructive surgery.

Future Prospects

 The promotion of multi-institutional studies on reconstructive surgery will provide our patients with high-precision and evidence-based medical services.

List of papers published in 2020

Journal

1. Kagaya Y, Arikawa M, Higashino T, Miyamoto S. Autologous abdominal wall reconstruction using anterolateral thigh and iliotibial tract flap after extensive tumor resection: A case series study of 50 consecutive cases. J Plast Reconstr Aesthet Surg, 73:638-650, 2020

2. Tsushima N, Shinozaki T, Fujisawa T, Tomioka T, Okano W, Ikeda M, Tahara M, Higashino T, Hayashi R. Salvage Reconstructive Surgery During Nivolumab Therapy for a Patient With Hypopharyngeal Cancer. Clin Med Insights Case Rep, 13:1179547620908854, 2020